MYX.AX · MAYNE PHARMA GROUP LIMITED
Australia · RS rating 46 · As of 2026-10-14
| Price | 2.69 AUD |
|---|---|
| 1-day change | +5.9% |
| RS rating (overall / 1M / 3M / 12M) | 46 / 29 / 44 / 19 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 22 / 15 / 11 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +57.3% |
| Market cap (USD) | $151.6M |